Rasco, D. W., Koganemaru, S., Koyama, T., Sharma, M. R., Champiat, S., Davar, D., Johanns, T. M., Spira, A. I., Elgeioushi, N., Sugibayashi, K., Andrew, D., Rodney, S., Luheshi, N., Hsiue, E., Sandhu, S. (2026). Phase I/II study of AZD6750, a CD8-guided interleukin-2 agent, alone and in combination with other anti-cancer agents in participants with advanced or metastatic solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2666